Issue 1/2023
Content (20 Articles)
Efficacy of dual checkpoint-blockade in solid tumors, part 1
Dora Niedersüß-Beke
Hodgkin lymphoma—how much therapy do we need?
Barbara Lehner, Michael Panny
Cutaneous lymphomas—fast facts about an orphan disease—a short review
Stefanie Porkert, Julia Valencak
Total neoadjuvant therapy in rectal cancer
Gudrun Piringer, Alexander De Vries
Surgical management of liver metastasis from colorectal cancer
Madita-Magdalena Tschoegl, Thomas Gruenberger
Update on systemic therapy for clear cell renal cell carcinoma
Josef Mühlmann
Biomarkers and translational research approaches in breast cancer—an update
Angelika M. Starzer, Anna S. Berghoff, Rupert Bartsch
Essential news for clinical practice—thyroid cancer
Barbara Kiesewetter, Ladislaia Wolff, Markus Raderer
Dual checkpoint-blockade in urothelial carcinoma—when is it so far
Karl Mayrhofer, Dora Niedersüß-Beke
Dual immune checkpoint blockade in gastroesophageal tumors: never say never
Aysegul Ilhan-Mutlu
Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review
Waltraud Elisabeth Huf, Arschang Valipour
Barriers to patient access of CAR T cell therapies in Austria
Georg Hopfinger, Bernhard Rupp, Richard Greil